These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


603 related items for PubMed ID: 16515684

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. The profile of mephedrone on human monoamine transporters differs from 3,4-methylenedioxymethamphetamine primarily by lower potency at the vesicular monoamine transporter.
    Pifl C, Reither H, Hornykiewicz O.
    Eur J Pharmacol; 2015 May 15; 755():119-26. PubMed ID: 25771452
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. MDMA (Ecstasy) and human dopamine, norepinephrine, and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment.
    Verrico CD, Miller GM, Madras BK.
    Psychopharmacology (Berl); 2007 Jan 15; 189(4):489-503. PubMed ID: 16220332
    [Abstract] [Full Text] [Related]

  • 5. The Pharmacological Profile of Second Generation Pyrovalerone Cathinones and Related Cathinone Derivative.
    Kolaczynska KE, Thomann J, Hoener MC, Liechti ME.
    Int J Mol Sci; 2021 Jul 31; 22(15):. PubMed ID: 34361040
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Monoamine transporter contributions to l-DOPA effects in hemi-parkinsonian rats.
    Conti MM, Meadows SM, Melikhov-Sosin M, Lindenbach D, Hallmark J, Werner DF, Bishop C.
    Neuropharmacology; 2016 Nov 31; 110(Pt A):125-134. PubMed ID: 27452719
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. The abuse-related effects of pyrrolidine-containing cathinones are related to their potency and selectivity to inhibit the dopamine transporter.
    Gannon BM, Baumann MH, Walther D, Jimenez-Morigosa C, Sulima A, Rice KC, Collins GT.
    Neuropsychopharmacology; 2018 Nov 31; 43(12):2399-2407. PubMed ID: 30305739
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The psychoactive aminoalkylbenzofuran derivatives, 5-APB and 6-APB, mimic the effects of 3,4-methylenedioxyamphetamine (MDA) on monoamine transmission in male rats.
    Brandt SD, Walters HM, Partilla JS, Blough BE, Kavanagh PV, Baumann MH.
    Psychopharmacology (Berl); 2020 Dec 31; 237(12):3703-3714. PubMed ID: 32875347
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro.
    Madras BK, Xie Z, Lin Z, Jassen A, Panas H, Lynch L, Johnson R, Livni E, Spencer TJ, Bonab AA, Miller GM, Fischman AJ.
    J Pharmacol Exp Ther; 2006 Nov 31; 319(2):561-9. PubMed ID: 16885432
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Pharmacological characterization of the aminorex analogs 4-MAR, 4,4'-DMAR, and 3,4-DMAR.
    Rickli A, Kolaczynska K, Hoener MC, Liechti ME.
    Neurotoxicology; 2019 May 31; 72():95-100. PubMed ID: 30776375
    [Abstract] [Full Text] [Related]

  • 18. Interaction Profiles of Central Nervous System Active Drugs at Human Organic Cation Transporters 1-3 and Human Plasma Membrane Monoamine Transporter.
    Angenoorth TJF, Stankovic S, Niello M, Holy M, Brandt SD, Sitte HH, Maier J.
    Int J Mol Sci; 2021 Nov 30; 22(23):. PubMed ID: 34884800
    [Abstract] [Full Text] [Related]

  • 19. Further characterisation of the interaction of haloperidol metabolites with neurotransmitter transporters in rat neuronal cultures and in transfected COS-7 cells.
    Siebert GA, Pond SM, Bryan-Lluka LJ.
    Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar 30; 361(3):255-64. PubMed ID: 10731037
    [Abstract] [Full Text] [Related]

  • 20. Potencies of haloperidol metabolites as inhibitors of the human noradrenaline, dopamine and serotonin transporters in transfected COS-7 cells.
    Bryan-Lluka LJ, Siebert GA, Pond SM.
    Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug 30; 360(2):109-15. PubMed ID: 10494878
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 31.